FDA’s Revised Electronic Source Data Guidance Less Specific On How Data Should Flow
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues its second draft on the topic in two years, going back to the drawing board after comments from industry, but BIO still hasn’t persuaded the agency to explicitly exempt electronic diaries.